Combined antiretroviral and anti-tuberculosis drug resistance following incarceration.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Do Incarcerated Populations Serve as a Reservoir for Tuberculosis in South Africa?The American journal of tropical medicine and hygiene · 2018
   Article
2. Including the criminal justice-involved at the HIV policy, research and service delivery table.Journal of the International AIDS Society · 2018
   Article
3. Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence.The Journal of infectious diseases · 2017
   Article
4. Exploring the drivers of health and healthcare access in Zambian prisons: a health systems approach.Health policy and planning · 2016
   Article
5. HIV and tuberculosis in prisons in sub-Saharan Africa.Lancet (London, England) · 2016
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

Abstract